Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009794HBVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS10036366HBVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058841HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058842HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058843HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058844HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058845HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058846HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058847HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058848HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TCGA Plot Options
Drug Information
GeneBCHE
DrugBank IDDB00941
Drug NameHexafluronium
Target IDBE0002180
UniProt IDP06276
Regulation Typeinhibitor
PubMed IDs948350; 11752352
CitationsSchuh FR: Interaction of hexafluorenium with human plasma cholinesterase in comparison with hexamethonium. Naunyn Schmiedebergs Arch Pharmacol. 1976;293(1):11-3.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved
Direct ClassificationHexamethonium compounds
SMILESC[N+](C)(CCCCCC[N+](C)(C)C1C2=C(C=CC=C2)C2=C1C=CC=C2)C1C2=C(C=CC=C2)C2=C1C=CC=C2
Pathways
PharmGKBPA164743020
ChEMBLCHEMBL1201349